Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

Enovis Corporation

Enovis is a medical technology company focused on developing clinically differentiated therapeutic solutions that generate measurably better patient outcomes and transform workflows.

msh id	COM:ENOVIS
symbol	ENOV
name	Enovis Corporation
homepage url	https://www.enovis.com
country	US
sector	Industrials
industry	Industrial - Machinery
market	STOCKS
employee count	6.55K
crunchbase url	-
linkedin url	-
founders	-

market cap	2.4B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.06
growth cost of revenue	0.03
growth depreciation and amortization	-0.01
growth ebitda	0.48
growth ebitda ratio	0.36
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	0.14
growth gross profit ratio	0.04

COM:ENOVIS

Enovis

Last Close

44.78

21/11 21:00

Market Cap

2.40B

Beta: -

Volume Today

542.77K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	1.76B
cost of revenue	1.76B
depreciation and amortization	217.1M
ebitda	194.39M
ebitda ratio	0.11
eps	-0.61
eps diluted	-0.61
operating expenses	1.04B
operating income	-65.71M
operating income ratio	-0.04

accounts receivables	-16.32M
capital expenditure	-122.22M
cash at beginning of period	24.3M
cash at end of period	44.83M
inventory	468.83M
working capital ttm	498.9M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-